Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 12
Submit an article Journal homepage
311
Views
6
CrossRef citations to date
0
Altmetric
Letters to the Editor

Acute promyelocytic leukemia (APL) with an IRF2BP2-RARA fusion transcript: an aggressive APL variant

Ahmad S. Alotaibia Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Mustafa Abdulrazzaqb Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Keyur P. Patelb Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Farhad Ravandia Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Sergej Konoplevb Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Carlos Bueso-Ramosb Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
C. Cameron Yinb Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Tariq Muzzafarb Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Guilin Tangb Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAORCID Iconhttps://orcid.org/0000-0002-9482-4806View further author information
ORCID Icon,
Andrew Futrealc Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Nitin Jaina Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
,
Marina Y. Konoplevaa Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USAView further author information
&
Naveen Pemmarajua Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
View further author information
 show all
Pages 3018-3020 | Received 07 May 2020, Accepted 30 Jun 2020, Published online: 11 Jul 2020

References

  • Abaza Y, Kantarjian H, Garcia-Manero G, et al. Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab. Blood. 2017;129(10):1275–1283.
  • Wen L, Xu Y, Yao L, et al. Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions. Haematologica. 2019;104(5):e195–e199.
  • Mannan A, Muhsen IN, Barragán E, et al. Genotypic and phenotypic characteristics of acute promyelocytic leukemia translocation variants. Hematol Oncol Stem Cell Ther. 2020. DOI:10.1016/j.hemonc.2020.05.007
  • Sobas M, Talarn-Forcadell MC, Martínez-Cuadrón D, et al. PLZF-RARα, NPM1-RARα, and other acute promyelocytic leukemia variants: the pethema registry experience and systematic literature review. Cancers. 2020;12(5):1313.
  • Ramalho-Oliveira R, Oliveira-Vieira B, Viola J. IRF2BP2: a new player in the regulation of cell homeostasis. J Leukoc Biol. 2019;106(3):717–723.
  • Yin CC, Jain N, Mehrotra M, et al. Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia. J Natl Compr Canc Netw. 2015;13(1):19–22.
  • Shimomura Y, Mitsui H, Yamashita Y, et al. New variant of acute promyelocytic leukemia with IRF2BP2-RARA fusion. Cancer Sci. 2016;107(8):1165–1168.
  • Jovanovic JV, Chillón MC, Vincent-Fabert C, et al. The cryptic IRF2BP2-RARA fusion transforms hematopoietic stem/progenitor cells and induces retinoid-sensitive acute promyelocytic leukemia. Leukemia. 2017;31(3):747–751.
  • Mazharuddin S, Chattopadhyay A, Levy MY, et al. IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid. Leuk Lymphoma. 2018;59(9):2246–2249.
  • Liu Y, Xu F, Hu H, et al. A rare case of acute promyelocytic leukemia with IRF2BP2-RARA fusion; and literature review. Onco Targets Ther. 2019;12:6157–6163.
  • Dimov ND, Medeiros LJ, Kantarjian HM, et al. Rapid and reliable confirmation of acute promyelocytic leukemia by immunofluorescence staining with an antipromyelocytic leukemia antibody: the M. D. Anderson Cancer Center experience of 349 patients. Cancer. 2010;116(2):369–376.
  • Chang H, Kuo M-C, Shih L-Y, et al. Acute promyelocytic leukemia-associated thrombosis. Acta Haematol. 2013;130(1):1–6.
  • Chen HH, Keyhanian K, Zhou X, et al. IRF2BP2 reduces macrophage inflammation and susceptibility to atherosclerosis. Circ Res. 2015;117(8):671–683.
  • Cruz SA, Hari A, Qin Z, et al. Loss of IRF2BP2 in microglia increases inflammation and functional deficits after focal ischemic brain injury. Front Cell Neurosci. 2017;11(July):1–10.
  • Nie L, Ma R, Yuan X, et al. The prognostic value of CD2, CD4, and HLA-DR expression and FLT3-ITD mutation in adult acute promyelocytic leukemia. Leuk Lymphoma. 2020;1–6. DOI:10.1080/10428194.2020.1768386
  • Sanz MA, Lo Coco F, Martin G, et al. Definition of relapse risk and role of nonanthracycline drags for consolidation in patients with acute promyelocytic leukemia: A joint study of the PETHEMA and GIMEMA cooperative groups. Blood. 2000;96(4):1247–1253.
  • Cai P, Wu Q, Wang Y, et al. An effective early death scoring system for predicting early death risk in de novo acute promyelocytic leukemia. Leuk Lymphoma. 2020:1–7. DOI:10.1080/10428194.2020.1742910
  • Daver N, Kantarjian H, Marcucci G, et al. Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis. Br J Haematol. 2015;168(5):646–653.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.